Dyadic International

Youtube Subscribe

Open: 2.05 Close: 2.2 Change: 0.15

What an AI can tell you about Dyadic International before investing.

This document will help you to evaluate Dyadic International without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Dyadic International are: Dyadic, International, Group, Chr, Soufflet, Amano, Enzymes, …

Concept Map

Semantic Network

Stock Summary

Dyadic International, Inc. develops, produces, and sells enzymes and other proteins. Company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate. Company has a research and development agreement with.

Today's Summary

Dyadic International, Soufflet Group, Amano Enzymes, BASF, Chr. Chr. 64.88M Dyadic.38M Great Elm Group 62.82M Telesis Bio 62.78M Market Cap Rankings. Dyadic International Estimates* in USD Yearly Quarterly   2023 2024 2025 2026 Revenue 6 19 6 45 Dividend Yield (in %) - - -- - - EPS -0.14 0.12 - 0.37 0.68 P/E Ratio -15.71 18.33 -5.95 3.

Today's News

Dyadic International, Soufflet Group, Amano Enzymes, BASF, Chr. Chr. 64.88M Dyadic.38M Great Elm Group 62.82M Telesis Bio 62.78M Market Cap Rankings. Dyadic International Estimates* in USD Yearly Quarterly   2023 2024 2025 2026 Revenue 6 19 6 45 Dividend Yield (in %) - - -- - - EPS -0.14 0.12 - 0.37 0.68 P/E Ratio -15.71 18.33 -5.95 3.

Stock Profile

"Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design, Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida."

Keywords

Are looking for the most relevant information about Dyadic International? Investor spend a lot of time searching for information to make investment decisions in Dyadic International. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Dyadic International are: Dyadic, International, Group, Chr, Soufflet, Amano, Enzymes, and the most common words in the summary are: view, covid19, follow, dyadic, january, nasdaq, international, . One of the sentences in the summary was: Dyadic International, Soufflet Group, Amano Enzymes, BASF, Chr. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #view #covid19 #follow #dyadic #january #nasdaq #international.

Read more →

Youtube Subscribe

---